EEG serves as an excellent objective biomarker of hypoxic ischemic encephalopathy, aiding in assessing severity, guiding treatment, detecting seizures, and predicting outcomes. Neonatal EEG interpretation challenges for nonexperts are mitigated by promising qEEG biomarkers and advanced ML techniques. Some of these innovations are already applied cot-side in NICUs, and further advances in artificial intelligence for automated, continuous EEG interpretation for neonates with HIE are anticipated.
Advances in Electroencephalographic Biomarkers of Neonatal Hypoxic Ischemic Encephalopathy
Proietti, Jacopo;
2024-01-01
Abstract
EEG serves as an excellent objective biomarker of hypoxic ischemic encephalopathy, aiding in assessing severity, guiding treatment, detecting seizures, and predicting outcomes. Neonatal EEG interpretation challenges for nonexperts are mitigated by promising qEEG biomarkers and advanced ML techniques. Some of these innovations are already applied cot-side in NICUs, and further advances in artificial intelligence for automated, continuous EEG interpretation for neonates with HIE are anticipated.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
